Logo

Xpogen Licenses PathlinX Software to Johns Hopkins

May 08, 2003

NEW YORK, May 8 - Bioinformatics company Xpogen today said it has licensed its PathlinX 3.0 gene expression-analysis software to Johns Hopkins Medical Center.

According to Cambridge, Mass.-based Xpogen, the PathlinX software was designed to identify differentially co-expressed genes in two-state method-of-action experiments.

 

"By creating visual networks of clinical and gene-expression data and integrating these results with more conventional techniques, we will be able to mine the genes that are key to a better understanding of the molecular mechanisms of pulmonary disease," said Joe Garcia, director of pulmonary and critical care Medicine at Johns Hopkins.

Breaking News
The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.